Abstract
More than half of the patients with a suspicion of mitochondrial disease remain undiagnosed, accentuating the great potential and continuing challenges in the molecular diagnosis of mitochondrial diseases. Mutations in non-coding regions, epigenetic changes, oligenic inheritance, and yet-to-be-discovered novel genes may contribute to the phenotypes in patients with a negative results for Mendelian disorder based on whole exome sequencing.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
